For the millions of Americans currently living with persistent symptoms, specialists at Sports Medicine of the Rockies and the Mayo Clinic suggest a multidisciplinary approach:
: The American Society of Anesthesiologists (ASA) reinforces the use of technique-based relief, such as fascial plane blocks, to reduce opioid needs after surgery [32]. Chronic
: Use heat/cold therapy and pacing to manage daily activity [25, 36]. For the millions of Americans currently living with
In late April 2026, the word "chronic" has dominated two very different headlines: the medical evaluations of top NFL prospects and a pivotal shift in how the FDA approaches long-term pain management. 1. The NFL Draft: The "Chronic" Red Dot Vince Clinical Research note that the 2025 draft
: In January 2025, the FDA approved Journavx (Suzetrigine) , the first non-opioid analgesic for moderate to severe acute pain, signaling a major step toward these new standards [33, 34].
: Experts at Dr. Vince Clinical Research note that the 2025 draft guidance introduces a flexible, mechanism-based framework. This allows drug developers to target shared pain pathways across multiple conditions rather than conducting duplicative trials for every specific ailment [2].
As the 2026 NFL Draft unfolded, "chronic" became the most feared word for high-tier athletes. The biggest story of the draft involved Tennessee cornerback Jermod McCoy , whose projected top-10 status plummeted due to a "medical red dot" concerning a chronic knee issue [24].